BioAge Labs, Inc.
BIOA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $59 | $34 | $31 |
| G&A Expenses | $19 | $15 | $9 |
| SG&A Expenses | $19 | $15 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $78 | $48 | $40 |
| Operating Income | -$78 | -$48 | -$40 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $7 | -$15 | $0 |
| Pre-Tax Income | -$71 | -$64 | -$40 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$71 | -$64 | -$40 |
| % Margin | – | – | – |
| EPS | -6.63 | -8.55 | -5.32 |
| % Growth | 22.5% | -60.7% | – |
| EPS Diluted | -6.63 | -8.55 | -5.32 |
| Weighted Avg Shares Out | 11 | 7 | 7 |
| Weighted Avg Shares Out Dil | 11 | 7 | 7 |
| Supplemental Information | – | – | – |
| Interest Income | $10 | $2 | $0 |
| Interest Expense | $2 | $8 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$69 | -$56 | -$39 |
| % Margin | – | – | – |